Free Trial

Talis Biomedical Q2 2023 Earnings Report

Talis Biomedical logo
$1.73 -0.11 (-6.11%)
(As of 12/20/2024 04:19 PM ET)

Talis Biomedical EPS Results

Actual EPS
-$8.27
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Talis Biomedical Revenue Results

Actual Revenue
$0.58 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Talis Biomedical Announcement Details

Quarter
Q2 2023
Time
N/A
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Talis Biomedical Earnings Headlines

Talis Biomedical Corp Ordinary Shares
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
See More Talis Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Talis Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Talis Biomedical and other key companies, straight to your email.

About Talis Biomedical

Talis Biomedical (NASDAQ:TLIS) operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

View Talis Biomedical Profile

More Earnings Resources from MarketBeat

Upcoming Earnings